David M Wood1, Pamela Conran, Paul I Dargan. 1. Guy's and St Thomas' NHS Foundation Trust and King's Healthcare Partners, Medical Toxicology Office, 2nd Floor, Bermondsey Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. david.wood@gstt.nhs.uk
Abstract
BACKGROUND: Hospital episode statistics (HES) and other health service utilisation data are based upon International Classification of Disease version 10 (ICD-10) diagnostic clinical codes used in relation to presentations to hospital. No previous studies have reported the validity of clinical coding in identifying patients who present with acute recreational drug toxicity. AIM: To determine the proportion of presentations with acute recreational drug toxicity that have been appropriately coded using the ICD-10 diagnostic coding system. DESIGN: Retrospective review of diagnostic codes applied to acute recreational drug toxicity presentations. METHODS: Presentations to the emergency department (ED) with acute recreational drug toxicity were identified for a 12-month period. Diagnostic codes applied to these presentations were obtained, and the proportion that were appropriate 'acute recreational drug toxicity' diagnostic codes was determined. RESULTS: There were 484 presentations with acute recreational drug toxicity between 1 January 2008 and 31 December 2008. 145 (30.0%) presentations had one or more diagnostic code(s) relating to that presentation. Of these, only 64 (44.1% of all coded presentations; 13.2% of all ED presentations) had been coded with a primary ICD-10 code that related to acute recreational drug toxicity. CONCLUSIONS: This study highlights that acute recreational drug toxicity presentations are not appropriately coded within the currently available ICD-10 clinical diagnostic codes. Further work is needed to determine how acute recreational drug toxicity-related presentations are coded by clinical coders to determine the optimal method to ensure that the true burden of acute recreational drug toxicity is captured and adequate services are provided for this burden.
BACKGROUND: Hospital episode statistics (HES) and other health service utilisation data are based upon International Classification of Disease version 10 (ICD-10) diagnostic clinical codes used in relation to presentations to hospital. No previous studies have reported the validity of clinical coding in identifying patients who present with acute recreational drug toxicity. AIM: To determine the proportion of presentations with acute recreational drug toxicity that have been appropriately coded using the ICD-10 diagnostic coding system. DESIGN: Retrospective review of diagnostic codes applied to acute recreational drug toxicity presentations. METHODS: Presentations to the emergency department (ED) with acute recreational drug toxicity were identified for a 12-month period. Diagnostic codes applied to these presentations were obtained, and the proportion that were appropriate 'acute recreational drug toxicity' diagnostic codes was determined. RESULTS: There were 484 presentations with acute recreational drug toxicity between 1 January 2008 and 31 December 2008. 145 (30.0%) presentations had one or more diagnostic code(s) relating to that presentation. Of these, only 64 (44.1% of all coded presentations; 13.2% of all ED presentations) had been coded with a primary ICD-10 code that related to acute recreational drug toxicity. CONCLUSIONS: This study highlights that acute recreational drug toxicity presentations are not appropriately coded within the currently available ICD-10 clinical diagnostic codes. Further work is needed to determine how acute recreational drug toxicity-related presentations are coded by clinical coders to determine the optimal method to ensure that the true burden of acute recreational drug toxicity is captured and adequate services are provided for this burden.
Authors: Hafid Narayan; Simon H L Thomas; Michael Eddleston; James W Dear; Euan Sandilands; D Nicholas Bateman Journal: Br J Clin Pharmacol Date: 2015-10-26 Impact factor: 4.335
Authors: Alison M Dines; David M Wood; Miguel Galicia; Christopher M Yates; Fridtjof Heyerdahl; Knut Erik Hovda; Isabelle Giraudon; Roumen Sedefov; Paul I Dargan Journal: J Med Toxicol Date: 2015-12
Authors: Natalie L McCarthy; James Baggs; Isaac See; Sujan C Reddy; John A Jernigan; Runa H Gokhale; Anthony E Fiore Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Dan Lewer; Joseph Freer; Emma King; Sarah Larney; Louisa Degenhardt; Emily J Tweed; Vivian D Hope; Magdalena Harris; Tim Millar; Andrew Hayward; Dan Ciccarone; Katherine I Morley Journal: Addiction Date: 2020-02-10 Impact factor: 7.256
Authors: D Nicholas Bateman; Robert Carroll; Janice Pettie; Takahiro Yamamoto; Muhammad E M O Elamin; Lucy Peart; Margaret Dow; Judy Coyle; Kristina R Cranfield; Christopher Hook; Euan A Sandilands; Aravindan Veiraiah; David Webb; Alasdair Gray; Paul I Dargan; David M Wood; Simon H L Thomas; James W Dear; Michael Eddleston Journal: Br J Clin Pharmacol Date: 2014-09 Impact factor: 4.335